Explore a comprehensive overview of clinical trial designs and protocols; including the four distinct phases, eligibility criteria, and essential methodologies.

Understand the critical aspects of regulatory compliance, and gain insights into how you can safeguard participant rights and ensuring the integrity of clinical research.

Selecting the right Contract Research Organization (CRO) is critical for the success of a clinical trial. This article outlines essential factors to consider during the selection process.

With a proven track record across diverse therapeutic areas, Australia is a cost-effective option as well as a strategic ally for biotech firms.

Southeast Asia has emerged as a pivotal region for vaccine clinical trials, driven by rapid recruitment, cost efficiency, and robust immunization infrastructure.

The biopharmaceutical industry is undergoing transformative changes to develop more dynamic and efficient frameworks that prioritize patient outcomes in 2025.

This guide to clinical trials explores the regulatory approval, study startup, and trial processes essential for advancing medical innovation.

Parkinson's disease affects over 8.5 million globally. Explore how advances in gene therapy, Deep Brain Stimulation, and innovative drugs are transforming treatment and improving patient outcomes.

Explore how COVID-19 has led to significant global morbidity and mortality. Advances in vaccines, therapies, and clinical trials are enhancing disease management and outcomes.

The global vaccine trial landscape is advancing rapidly, driven by new technologies and evolving regulations. Explore the answers to six questions about this rapidly evolving field.

Advances in immunotherapy, targeted drugs, and clinical trials are improving outcomes for bladder cancer patients, addressing regional disparities and accessibility challenges worldwide.

Small cell lung cancer (SCLC) is a fast-growing, aggressive lung cancer subtype. Global incidence, innovative therapies, and personalized medicine are transforming treatment outcomes and survival rates.

Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma subtype, has varied molecular profiles, global incidence, innovative drugs, and trials improving treatment strategies and patient outcomes.

The landscape of cell and gene therapy is advancing rapidly, revolutionizing healthcare by offering novel treatments for cancer, rare genetic conditions, and hematological diseases.

Gain insights into the evolving landscape of gastric cancer care and examine significant advancements and ongoing challenges in the fight against this formidable disease.

Pancreatic cancer, an aggressive gastrointestinal malignancy, presents a significant global health challenge. Delve into the current state of research and discover emerging therapeutic strategies.

In this FAQ, we delve into various aspects of Chronic Lymphocytic Leukemia (CLL), including its incidence and prevalence, the latest clinical trials, and the development of innovative drug therapies.

Whether you’re a researcher, clinician, or industry professional, our FAQs will equip you with essential knowledge on the advancements and challenges in RNA therapy development.

This FAQ delves into the latest advancements in the treatment of oesophageal cancer, highlighting cutting-edge drugs, ongoing clinical trials, and their potential to improve patient outcomes.

This FAQ section delves into non-small cell lung cancer (NSCLC) incidence, current trials, innovative drugs, and their effects on patient outcomes.

This FAQ examines advancements in liver cancer treatment, emphasizing innovative drugs, current clinical trials, and their potential effects on patient outcomes.

Novotech’s vice president emphasizes the expanding clinical presence in the APAC region, with a focus on Australia and South Korea.

This FAQ delves into the latest developments in endometrial cancer treatment, highlighting innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.

Explore the essential considerations for sponsors and CROs as they navigate the advantages and challenges of clinical trial locations, particularly in the United States and Europe.

Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.

Explore the exciting advancements in CNG treatment, such as innovative therapies, ongoing clinical trials, and their potential to positively influence patient outcomes.

With ongoing technological advancements, consider several factors as to why experts believe that Virtual Clinical Trials will continue to play a significant role even beyond the post-pandemic era, despite its unique set of challenges.

Delve into the swiftly evolving trends that are reshaping the clinical trial industry and examine potential implications for introducing innovative solutions to the market.

Contract research organizations can be invaluable partners in clinical trials. Dive into the full spectrum of benefits you'll experience by partnering with a globally established and well-resourced CRO.

Discover the advantages of incorporating Europe and APAC regions in clinical trial endeavors, such as accelerated recruitment, streamlined regulatory procedures, access to diverse patient populations, and ultimately, significant cost reductions.

Consider the advantages associated with conducting early- to late-phase clinical trials in China and the broader APAC region, as well as potential challenges that could impact the trial process and patient outcomes

Gain insight into how teams can create clinical pathways and develop trial designs made for success.

Get a full overview of the role CROs play in clinical trials and their impact on site selection, site monitoring, patient recruitment, managing data, and more.

Gain a better understanding of the global clinical trial landscape of Non-Hodgkin lymphoma (NHL) and its trends in the Asia Pacific.

Unearth how health officials are preparing to meet the rising demand for resources regarding liver cancer and ensure effective management throughout the cancer pathway.

Get a full overview of the current clinical trial landscape as it relates to HNC and where treatment efforts are headed in the future.

Uncover how pipeline drugs, especially small molecules, offer the potential to transform gallbladder cancer management, ultimately improving patient outcomes and addressing its global impact.

Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.

Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.

Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.

Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.

Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.

Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.

Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.

Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.

In December 2019, a novel coronavirus was discovered in China causing severe acute respiratory syndrome-like pneumonia which resulted in a pandemic. Find out more details regarding its spread in this report.

Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients

This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.

Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.

Explore how this partnership aims to contribute to the success of the trial by leveraging global resources and streamlining processes for efficient and timely results.

Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.